Works matching DE "VALSARTAN"

Results: 809

The impact of sacubitril/valsartan on catheter ablation for atrial fibrillation complicated with hypertension: A comprehensive retrospective analysis.

Published in:

Polish Heart Journal / Kardiologia Polska, 2025, v. 83, n. 5, p. 615, doi. 10.33963/v.phj.104573

By:

Rongbing Peng;
Ke Li;
Jianhan Yao;
Chao Liu;
Feifei Dong;
Zhifu Guo;
Manli Yu

Publication type:

Article

Model parameters influencing the cost-effectiveness of sacubitril/valsartan in heart failure: evidence from a systematic literature review.

Published in:

European Journal of Health Economics, 2023, v. 24, n. 3, p. 453, doi. 10.1007/s10198-022-01485-3

By:

Proudfoot, Clare;
Gautam, Raju;
Cristino, Joaquim;
Agrawal, Rumjhum;
Thakur, Lalit;
Tolley, Keith

Publication type:

Article

Acute Effects of Sacubitril/Valsartan with Initial Initiation in Pediatric Patients in the Cardiac Intensive Care Unit.

Published in:

Pediatric Cardiology, 2024, v. 45, n. 6, p. 1359, doi. 10.1007/s00246-023-03138-5

By:

Loomba, Rohit S.;
Ikeda, Nobuyuki;
Dorsey, Vincent;
Yousaf, Faeeq;
Nelson-McMillan, Kristen

Publication type:

Article

Sacubitril/valsartan compared to equivalent/sub-equivalent dose angiotensin receptor blocker or angiotensin-converting enzyme inhibitor in heart failure with reduced ejection fraction: a meta-analysis of randomized trials.

Published in:

European Journal of Clinical Pharmacology, 2024, v. 80, n. 8, p. 1113, doi. 10.1007/s00228-024-03686-6

By:

Rindone, Joseph P.;
Mellen, Chadwick K.

Publication type:

Article

Effects of sacubitril/valsartan on exercise capacity: a prognostic improvement that starts during uptitration.

Published in:

European Journal of Clinical Pharmacology, 2023, v. 79, n. 9, p. 1173, doi. 10.1007/s00228-023-03527-y

By:

Mapelli, Massimo;
Mattavelli, Irene;
Paolillo, Stefania;
Salvioni, Elisabetta;
Magrì, Damiano;
Galotta, Arianna;
De Martino, Fabiana;
Mantegazza, Valentina;
Vignati, Carlo;
Esposito, Immacolata;
Dell'Aversana, Simona;
Paolillo, Roberta;
Capovilla, Teresa;
Tamborini, Gloria;
Nepitella, Alessandro Alberto;
Filardi, Pasquale Perrone;
Agostoni, Piergiuseppe

Publication type:

Article

A collaborative study of the impact of N-nitrosamines presence and ARB recall on ARB utilization – results from IQVIA™ Disease Analyzer Germany.

Published in:

European Journal of Clinical Pharmacology, 2023, v. 79, n. 6, p. 849, doi. 10.1007/s00228-022-03439-3

By:

Hedenmalm, Karin;
Quinten, Chantal;
Kurz, Xavier;
Bradley, Marie;
Lee, Hana;
Eworuke, Efe

Publication type:

Article

Association between the NEP rs701109 polymorphism and the clinical efficacy and safety of sacubitril/valsartan in Chinese patients with heart failure.

Published in:

European Journal of Clinical Pharmacology, 2023, v. 79, n. 5, p. 663, doi. 10.1007/s00228-023-03484-6

By:

Luo, Hong-Yu;
Gao, Li-Chen;
Long, Hui-Zhi;
Zhou, Zi-Wei;
Xu, Shuo-Guo;
Li, Feng-Jiao;
Li, Hong-Li;
Cheng, Yan;
Li, Cai-Xia;
Peng, Xing-Yu;
Li, Liang;
Chen, Ran;
Deng, Ping

Publication type:

Article

Low- vs high-dose ARNI effects on clinical status, exercise performance and cardiac function in real-life HFrEF patients.

Published in:

European Journal of Clinical Pharmacology, 2022, v. 78, n. 1, p. 19, doi. 10.1007/s00228-021-03210-0

By:

Corrado, Egle;
Dattilo, Giuseppe;
Coppola, Giuseppe;
Morabito, Claudia;
Bonni, Enrico;
Zappia, Luca;
Novo, Giuseppina;
de Gregorio, Cesare

Publication type:

Article

Effect of SAcubitril/Valsartan on left vEntricular ejection fraction and on the potential indication for Implantable Cardioverter Defibrillator in primary prevention: the SAVE-ICD study.

Published in:

European Journal of Clinical Pharmacology, 2021, v. 77, n. 12, p. 1835, doi. 10.1007/s00228-021-03189-8

By:

Guerra, Federico;
Ammendola, Ernesto;
Ziacchi, Matteo;
Aspromonte, Vittorio;
Pellegrino, Pier Luigi;
Del Giorno, Giuseppe;
Dell'Era, Gabriele;
Pimpini, Lorenzo;
Santoro, Francesco;
Floris, Roberto;
Stronati, Giulia;
Nigro, Gerardo;
Paolisso, Pasquale;
Guido, Alessandro;
Maglia, Giampiero;
Brunetti, Natale Daniele;
Carbone, Angelo;
Gravellone, Miriam;
Antonicelli, Roberto;
Cannone, Michele

Publication type:

Article

A systematic approach for introduction of novel treatments to a chronic patient group: sacubitril-valsartan as a case study.

Published in:

European Journal of Clinical Pharmacology, 2021, v. 77, n. 1, p. 125, doi. 10.1007/s00228-020-02979-w

By:

Norberg, Helena;
Bergdahl, Ellinor;
Ängerud, Karin Hellström;
Lindmark, Krister

Publication type:

Article

Pharmacodynamic interaction between intravenous nitroglycerin and oral sacubitril/valsartan (LCZ696) in healthy subjects.

Published in:

European Journal of Clinical Pharmacology, 2018, v. 74, n. 9, p. 1121, doi. 10.1007/s00228-018-2509-2

By:

Schuehly, Uwe;
Ayalasomayajula, Surya;
Buchbjerg, Jeppe;
Pal, Parasar;
Golor, Georg;
Prescott, Margaret F.;
Sunkara, Gangadhar;
Hinder, Markus;
Langenickel, Thomas H.

Publication type:

Article

Repaglinide-irbesartan drug interaction: effects of SLCO1B1 polymorphism on repaglinide pharmacokinetics and pharmacodynamics in Chinese population.

Published in:

European Journal of Clinical Pharmacology, 2018, v. 74, n. 8, p. 1021, doi. 10.1007/s00228-018-2477-6

By:

Pei, Qi;
Liu, Jun-Yan;
Yin, Ji-Ye;
Yang, Guo-Ping;
Liu, Shi-Kun;
Zheng, Yi;
Xie, Pan;
Guo, Cheng-Xian;
Luo, Mi;
Zhou, Hong-Hao;
Li, Xi;
Liu, Zhao-Qian

Publication type:

Article

Serious adverse drug reactions with sacubitril/valsartan Entresto®: a French pharmacovigilance survey.

Published in:

2018

By:

Moulis, Florence;
Rousseau, Vanessa;
Chebane, Leila;
Gouverneur, Amandine;
Gaboriau, Louise;
Faillie, Jean-Luc;
Durrieu, Geneviève;
Montastruc, François;
Montastruc, Jean-Louis

Publication type:

Letter to the Editor

Recent major advances in cardiovascular pharmacotherapy.

Published in:

European Journal of Clinical Pharmacology, 2018, v. 74, n. 7, p. 853, doi. 10.1007/s00228-018-2453-1

By:

Milner, James;
Cunha, Andreia;
Gamboa-Cruz, Carlota;
Reis, Julie;
Campos, Márcia;
António, Natália

Publication type:

Article

Effect of renal function on the pharmacokinetics of LCZ696 (sacubitril/valsartan), an angiotensin receptor neprilysin inhibitor.

Published in:

European Journal of Clinical Pharmacology, 2016, v. 72, n. 9, p. 1065, doi. 10.1007/s00228-016-2072-7

By:

Ayalasomayajula, Surya;
Langenickel, Thomas;
Jordaan, Pierre;
Zhou, Wei;
Chandra, Priyamvada;
Albrecht, Diego;
Pal, Parasar;
Rajman, Iris;
Sunkara, Gangadhar

Publication type:

Article

Single therapeutic and supratherapeutic doses of sacubitril/valsartan (LCZ696) do not affect cardiac repolarization.

Published in:

European Journal of Clinical Pharmacology, 2016, v. 72, n. 8, p. 917, doi. 10.1007/s00228-016-2062-9

By:

Langenickel, Thomas;
Jordaan, Pierre;
Petruck, Jesika;
Kode, Kiran;
Pal, Parasar;
Vaidya, Soniya;
Chandra, Priya;
Rajman, Iris

Publication type:

Article

Comparative Efficacy of Irbesartan/ Hydrochlorothiazide and Valsartan/Hydrochlorothiazide Combination in Lowering Blood Pressure: A Retrospective Observational Study in Oman.

Published in:

Medical Principles & Practice, 2013, v. 22, n. 3, p. 265, doi. 10.1159/000345389

By:

Al Balushi, K.A.;
Habib, J.Q.;
Al-Zakwani, I.

Publication type:

Article

Could ARNI have an Effect on LV Fibrosis and Inflammatory Parameters in an Experimental Autoimmune Myocarditis Model?

Published in:

Eurasian Journal of Medical Investigation, 2022, v. 6, n. 2, p. 190, doi. 10.14744/ejmi.2022.80484

By:

Duygu, Ali;
Gazi, Emine;
Deveci, Bulent;
Arslan, Mehmet;
Oztopuz, Rahime Ozlem;
Adali, Yasemen

Publication type:

Article

HEART FAILURE: AN OVERALL ASSESSMENT.

Published in:

2023

By:

Vartela, Vasiliki

Publication type:

Editorial

A Selective and Accurate LC-MS/MS Method for Simultaneous Quantification of Valsartan and Hydrochlorothiazide in Human Plasma.

Published in:

Separations (2297-8739), 2023, v. 10, n. 2, p. 119, doi. 10.3390/separations10020119

By:

Haque, Anzarul;
Iqbal, Muzaffar;
Alamoudi, Mariam K.;
Alam, Prawez

Publication type:

Article

Development, Validation and Application of a Novel UHPLC-UV Method for the Simultaneous Determination of Valsartan and Nifedipine in the New Formulation of Self-Nanoemulsifying Drug Delivery Systems.

Published in:

Separations (2297-8739), 2022, v. 9, n. 11, p. 325, doi. 10.3390/separations9110325

By:

Rashid, Md Abdur;
Bilani, Mohammad;
Shazly, Gamal;
Kazi, Mohsin

Publication type:

Article

The Inflation Reduction Act and Patient Costs for Drugs to Treat Heart Failure.

Published in:

JAMA Network Open, 2024, v. 7, n. 10, p. e2441915, doi. 10.1001/jamanetworkopen.2024.41915

By:

Trish, Erin;
Van Nuys, Karen;
Wu, Joanne;
Desai, Nihar R.

Publication type:

Article

Kidney Outcomes Following Angiotensin Receptor-Neprilysin Inhibitor vs Angiotensin-Converting Enzyme Inhibitor/Angiotensin Receptor Blocker Therapy for Thrombotic Microangiopathy.

Published in:

JAMA Network Open, 2024, v. 7, n. 9, p. e2432862, doi. 10.1001/jamanetworkopen.2024.32862

By:

Li, Jianbo;
Liu, Qinghua;
Lian, Xingji;
Yang, Shicong;
Lian, Rong;
Li, Wenchuan;
Yu, Jianwen;
Huang, Fengxian;
Chen, Wenfang;
He, Feng;
Chen, Wei

Publication type:

Article

Sacubitril-Valsartan in Patients Requiring Hemodialysis.

Published in:

JAMA Network Open, 2024, v. 7, n. 8, p. e2429237, doi. 10.1001/jamanetworkopen.2024.29237

By:

Le, Dustin;
Grams, Morgan E.;
Coresh, Josef;
Shin, Jung-Im

Publication type:

Article

AMLODIPINE- AND VALSARTAN - ENHANCED END ORGAN PROTECTION IN STREPTOZOTOCIN-INDUCED TYPE 2 DIABETIC RATS TREATED WITH METFORMIN.

Published in:

Journal of Pharmaceutical & Allied Sciences, 2023, v. 20, n. 1, p. 3859

By:

BOLANLE, I. O.;
AKHIGBEMEN, A. M.;
OMOGBAI, E. K. I.

Publication type:

Article

Impact of Sacubitril/Valsartan on the Long-Term Incidence of Ventricular Arrhythmias in Chronic Heart Failure Patients.

Published in:

Journal of Clinical Medicine, 2019, v. 8, n. 10, p. 1582, doi. 10.3390/jcm8101582

By:

El-Battrawy, Ibrahim;
Pilsinger, Christina;
Liebe, Volker;
Lang, Siegfried;
Kuschyk, Jürgen;
Zhou, Xiaobo;
Borggrefe, Martin;
Röger, Susanne;
Akin, Ibrahim

Publication type:

Article

Amlodipine and valsartan improving effect on the survival rate and deleterious pathological changes in streptozotocin-induced diabetic rats treated with metformin.

Published in:

Pharmaceutical & Biomedical Research, 2019, v. 5, n. 2, p. 25

By:

Bolanle, Israel Olapeju;
Omogbai, Eric Kelly Inanemo;
Bafor, Enitome Evi

Publication type:

Article

Sacubitril/valsartan, sodium‐glucose cotransporter 2 inhibitors and vericiguat for congestive heart failure therapy.

Published in:

Basic & Clinical Pharmacology & Toxicology, 2022, v. 130, n. 4, p. 425, doi. 10.1111/bcpt.13714

By:

Norre, Tobias;
Grimm, Daniela;
Simonsen, Ulf

Publication type:

Article

The Combination of Valsartan and Sacubitril in the Treatment of Hypertension and Heart Failure - an Update.

Published in:

Basic & Clinical Pharmacology & Toxicology, 2018, v. 122, n. 1, p. 9, doi. 10.1111/bcpt.12912

By:

Nielsen, Peter Munch;
Grimm, Daniela;
Wehland, Markus;
Simonsen, Ulf;
Krüger, Marcus

Publication type:

Article

LCZ696 (Valsartan/Sacubitril) - A Possible New Treatment for Hypertension and Heart Failure.

Published in:

Basic & Clinical Pharmacology & Toxicology, 2016, v. 118, n. 1, p. 14, doi. 10.1111/bcpt.12453

By:

Andersen, Mathilde Borring;
Simonsen, Ulf;
Wehland, Markus;
Pietsch, Jessica;
Grimm, Daniela

Publication type:

Article

DEVELOPMENT AND VALIDATION OF HPLC METHOD FOR SIMULTANEOUS ESTIMATION OF VALSARTAN AND NEBIVOLOL IN DOSAGE FORM.

Published in:

International Journal of Chemical & Pharmaceutical Analysis, 2017, v. 4, n. 4, p. 1, doi. 10.21276/ijcpa

By:

Chate, Prajakta Uttam;
Kalshetti, Mallinath Shankareppa;
Patil, Ravikant Yashwantrao

Publication type:

Article

Effect of sacubitril–valsartan on the incidence of atrial fibrillation: A meta‐analysis.

Published in:

Journal of Cardiovascular Electrophysiology, 2023, v. 34, n. 4, p. 1037, doi. 10.1111/jce.15880

By:

Mohammad, Zoya;
Ahmad, Javaria;
Sultan, Ali;
Penagaluri, Ashritha;
Morin, Daniel;
Dominic, Paari

Publication type:

Article

Sacubitril/valsartan: An antiarrhythmic drug?

Published in:

Journal of Cardiovascular Electrophysiology, 2022, v. 33, n. 11, p. 2375, doi. 10.1111/jce.15670

By:

Huang, Elaine;
Bernard, Michael L.;
Elise Hiltbold, A.;
Khatib, Sammy;
Polin, Glenn M.;
Rogers, Paul A.;
Dominic, Paari;
Morin, Daniel P.

Publication type:

Article

Sacubitril/Valsartan in the Management of Heart Failure Patients with Cardiac Implantable Electronic Devices.

Published in:

American Journal of Cardiovascular Drugs, 2021, v. 21, n. 4, p. 383, doi. 10.1007/s40256-020-00448-4

By:

Cheng, Sijing;
Zhang, Nixiao;
Hua, Wei

Publication type:

Article

Effect of Sacubitril/Valsartan on Neurocognitive Function: Current Status and Future Directions.

Published in:

American Journal of Cardiovascular Drugs, 2021, v. 21, n. 3, p. 267, doi. 10.1007/s40256-020-00445-7

By:

Galo, Jason;
Celli, Diego;
Colombo, Rosario

Publication type:

Article

The AWAKE-HF Study: Sacubitril/Valsartan Impact on Daily Physical Activity and Sleep in Heart Failure.

Published in:

American Journal of Cardiovascular Drugs, 2021, v. 21, n. 2, p. 241, doi. 10.1007/s40256-020-00440-y

By:

Khandwalla, Raj M.;
Grant, Daniel;
Birkeland, Kade;
Heywood, J. Thomas;
Fombu, Emmanuel;
Owens, Robert L.;
Steinhubl, Steven R.

Publication type:

Article

Utilization of Sacubitril/Valsartan in Real-World Settings.

Published in:

2020

By:

Eworuke, Efe;
Menzin, Talia J.;
Welch, Emily C.;
Kolonoski, Joy;
Huang, Ting-Ying

Publication type:

Letter

Potential Uses of Sacubitril/Valsartan: Need for Data on Efficacy and Safety.

Published in:

American Journal of Cardiovascular Drugs, 2019, v. 19, n. 1, p. 1, doi. 10.1007/s40256-018-0306-z

By:

Huet, Fabien;
Akodad, Mariama;
Kalmanovitch, Eran;
Adda, Jerome;
Agullo, Audrey;
Batistella, Pascal;
Roubille, Camille;
Roubille, François

Publication type:

Article

Focused Treatment of Heart Failure with Reduced Ejection Fraction Using Sacubitril/Valsartan.

Published in:

American Journal of Cardiovascular Drugs, 2018, v. 18, n. 6, p. 473, doi. 10.1007/s40256-018-0280-5

By:

Liu, Rex C.

Publication type:

Article

Cost-Effectiveness Analysis of Sacubitril-Valsartan Compared with Enalapril in Patients with Heart Failure with Reduced Ejection Fraction in Thailand.

Published in:

American Journal of Cardiovascular Drugs, 2018, v. 18, n. 5, p. 405, doi. 10.1007/s40256-018-0288-x

By:

Krittayaphong, Rungroj;
Permsuwan, Unchalee

Publication type:

Article

Stable but Progressive Nature of Heart Failure: Considerations for Primary Care Physicians.

Published in:

American Journal of Cardiovascular Drugs, 2018, v. 18, n. 5, p. 333, doi. 10.1007/s40256-018-0277-0

By:

Anand, Inder

Publication type:

Article

Evaluating the Safety and Tolerability of Sacubitril/Valsartan for HFrEF Managed Within a Pharmacist Clinic.

Published in:

American Journal of Cardiovascular Drugs, 2018, v. 18, n. 2, p. 143, doi. 10.1007/s40256-018-0264-5

By:

Pogge, Elizabeth K.;
Davis, Lindsay E.

Publication type:

Article

Pharmacokinetics, Tolerability, and Safety of the Single Oral Administration of AGSAV301 vs Exforge: A Randomized Crossover Study of Healthy Male Volunteers.

Published in:

American Journal of Cardiovascular Drugs, 2014, v. 14, n. 1, p. 63, doi. 10.1007/s40256-013-0051-2

By:

Choi, Hee;
Kim, Yo;
Kim, Mi;
Noh, Yook-Hwan;
Lee, Shi;
Bae, Kyun-Seop;
Lim, Hyeong-Seok

Publication type:

Article

Comparing Antihypertensive Effect and Plasma Ciclosporin Concentration between Amlodipine and Valsartan Regimens in Hypertensive Renal Transplant Patients Receiving Ciclosporin Therapy.

Published in:

American Journal of Cardiovascular Drugs, 2011, v. 11, n. 6, p. 401, doi. 10.2165/11593800-000000000-00000

By:

Jingjing Cai;
Zhijun Huang;
Guoping Yang;
Ke Cheng;
Qifa Ye;
Yingzi Ming;
Xiaocong Zuo;
Peipei Zhou;
Hong Yuan

Publication type:

Article

Aliskiren as Add-On Therapy in the Treatment of Hypertensive Diabetic Patients Inadequately Controlled with Valsartan/HCT Combination: A Placebo-Controlled Study.

Published in:

American Journal of Cardiovascular Drugs, 2011, v. 11, n. 5, p. 327, doi. 10.2165/11591970-000000000-00000

By:

Drummond, W.;
Sirenko, Y. M.;
Ramos, E.;
Baek, I.;
Keefe, D. L.

Publication type:

Article

ACE Inhibition Modulates Endothelial Apoptosis and Renewal via Endothelial Progenitor Cells in Patients with Acute Coronary Syndromes.

Published in:

American Journal of Cardiovascular Drugs, 2011, v. 11, n. 3, p. 189, doi. 10.2165/11589400-000000000-00000

By:

Cangiano, Elisa;
Marchesini, Jlenia;
Campo, Gianluca;
Francolini, Gloria;
Fortini, Cinzia;
Carrà, Giacomo;
Miccoli, Matteo;
Ceconi, Claudio;
Tavazzi, Luigi;
Ferrari, Roberto

Publication type:

Article

The Role of Angiotensin Receptor Blocker and Calcium Channel Blocker Combination Therapy in Treating Hypertension.

Published in:

American Journal of Cardiovascular Drugs, 2010, v. 10, n. 5, p. 315, doi. 10.2165/11538850-000000000-00000

By:

Chrysant, Steven G.

Publication type:

Article

Cost Effectiveness of Angiotensin Receptor Blocker Monotherapy in Patients with Hypertension in the Netherlands: A Comparative Analysis Using Clinical Trial and Drug Utilization Data.

Published in:

American Journal of Cardiovascular Drugs, 2010, v. 10, n. 1, p. 49, doi. 10.2165/11319570-000000000-00000

By:

Boersma, Cornelis;
Voors, Adriaan A.;
Visser, Sipke T.;
de Jong-van den Berg, Lolkje T. W.;
Postma, Maarten J.

Publication type:

Article

The Cost Effectiveness and Cost Utility of Valsartan in Chronic Heart Failure Therapy in Italy: A Probabilistic Markov Model.

Published in:

American Journal of Cardiovascular Drugs, 2009, v. 9, n. 6, p. 383, doi. 10.2165/11315730-000000000-00000

By:

Pradelli, Lorenzo;
Iannazzo, Sergio;
Zaniolo, Orietta

Publication type:

Article

Amlodipine/Valsartan/Hydrochlorothiazide: Fixed-Dose Combination in Hypertension.

Published in:

American Journal of Cardiovascular Drugs, 2009, v. 9, n. 6, p. 411, doi. 10.2165/11204350-000000000-00000

By:

Deeks, Emma D.

Publication type:

Article